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Background: Impaired fasting glycaemia (IFG) has been defined as the fasting plasma glucose level between 6.1
(110 mgl/dl) and 6.9 mmol/l (125 mgl/dl). Control of hyperglycaemia during acute illness among diabetic and non-
diabetic patients has been associated with improved outcome. The aim of this study was to investigate the
prevalence of and factors related to hyperglycaemia, IFG and diabetes in west of Iran.
Methods: This project was performed by a cross-sectional method in Ilam province including 2158 people ≥
25 years old. From the list of all rural and urban health centers of each county, several were randomly selected. For
each selected health centre, families numbered 1–20 completed questionnaire forms for all the members aging ≥
25 years. FBS was measured for all the participants by standard method. All the demographic and laboratory results
were analysed using SPSS 16. Descriptive and regression analysis were used for statistical analysis appropriately.
Results: A total of 2158 people were evaluated in this study, among which 72 % were female with a mean age of
45.5 ± 14 years. 40 % of participants were from urban regions and the mean height, weight, FBS and waist size of
the participants were respectively as follows: 164 ± 8.9 cm, 68.4 ± 12.3 kg, 5.7 ± 2.8 mmol/l (102.6 ± 49.9 mg/dl) and
82.3 ± 14.3 cm. The prevalence of IFG, diabetes and hyperglycaemia among participants were 7.8 %, 11.8 % and
19.6 %, respectively and participants from urban area showed a significantly higher prevalence of hyperglycaemia
compared to rural regions (P < 0.0001).
Conclusion: The most effective factors associated with IFG and diabetes were family history of diabetes, age,
hypertension, marital status, place of life and smoking, respectively. The prevalence of IFG, diabetes and
hyperglycemia among the population living in Ilam province, west of Iran, were 7.8, 11.8 and 19.6 % respectively
which were directly increased with age.
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Plasma glucose is a continuous variable, with no definite
“cut off” between normal and abnormal levels. High
levels are usually associated with diabetes mellitus; how-
ever, relatively high levels may be detected in hospitalised
patients in the absence of diabetes. Diagnostic criteria for
diabetes are based on epidemiological evidences that iden-
tify levels, which predict the risk of future complications.
Current diagnostic criteria were recently revised by the* Correspondence: abangah_gh@yahoo.com
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states of glucose intolerance are well recognised. Impaired
glucose tolerance (IGT) [1] is diagnosed when the fasting
plasma glucose is <7.0 mmol/l (126 mgl/dl), and 2-hour
post-glucose load level is between 7.8 (140 mgl/dl) and
11.0 mmol/l (199 mgl/dl). More recently, “impaired fast-
ing glycaemia” (IFG) has been defined, where the fasting
plasma glucose level is between 6.1 (110 mgl/dl) and
6.9 mmol/l (125 mgl/dl) [1]. Both IGT and IFG probably
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betes, as well as of cardiovascular diseases [2].
Some, but by no means all, patients admitted with hyper-
glycaemia have diabetes, so either known or unknown dia-
betes may be a cause of admission hyperglycaemia. There
are evidences that at least some of these patients may have
previously had undiagnosed diabetes [3].
Hyperglycaemia is common in hospital in-patients. A
study from the USA has shown that more than one-
third (38 %) of all patients admitted to an urban
general hospital had fasting blood glucose levels ex-
ceeding 7.0 mmol/l, or 2 or more random blood glu-
cose levels exceeding 11.1 mmol/l [4]. Another study
investigated unrecognised diabetes among patients
with coronary diseases and found that 46.6 % of the
patients had hyperglycaemia with no prior history of
diabetes [5].
In the UK, about 1.4 million people are known to have
diabetes (about 3 % prevalence) and another million
(2 % of the population) have undiagnosed diabetes [6].
This prevalence is grossly similar to that in other coun-
tries. Studies from developed countries reported preva-
lence rates of 7–38 % and mortality rates of 7.6–16 %
associated with diabetes among general hospital admis-
sions [4, 5, 7–12]. Globally, it was estimated that 382
million people suffered from diabetes with a prevalence
rate of 8.3 % in 2013. North America and the Caribbean
are the regions with the higher prevalence rates of dia-
betes with a figure of 11 %, followed by the Middle East
and North Africa with a prevalence rate of 9.2 % and
Western Pacific regions, with a prevalence rate of 8.6 %,
closed to the global prevalence of diabetes. The number
of people with diabetes is expected to rise to 592 million
by 2035. Most people with diabetes live in low and
middle-income countries which will experience the
greatest increase in cases of diabetes over the next
22 years [13].
Although diabetes mellitus and impaired glucose
tolerance are worldwide health problems, hypergly-
caemia alone can also create major health disorders.
These disorders involve people either in developed or
developing countries. Studies from developing coun-
tries [14–16] broadly show similar prevalence rates of
diabetes to those found in developed nations; however,
this is changing. For example a study from urban Co-
lombian community showed that glucose intolerance
was common and noted that it was likely to increase
in the future urbanization and aging of the population
[12]. This is a major concern in all the developing
nations.
Treatment of diabetes involves medicines, diet, and
exercise to control blood glucose and prevent symp-
toms and problems. Keeping an ideal body weight
and an active lifestyle may prevent type 2 diabetes.There is no way to prevent type 1 diabetes. The
current population-based study was launched to in-
vestigate the prevalence of and factors related to
hyperglycaemia, IFG and diabetes in Ilam province in
the west of Iran.
Methods
Study population
This project was performed by a cross-sectional method
in Ilam province, which included 2158 cases ≥ 25 years
old during 2011–2012. Ilam province is located at the
west part of Iran with about 450 km line border with
Iraq and, according to the census of 2012, with a popu-
lation of 557,599 people. Rural and urban population of
this province are 215,040 and 342,559 and their relevant
number of people ≥ 25 years old are 107,052 and
173,367 respectively.
Sampling method
The sample size needed for this project was estimated
for 2158 people. The samples were selected by a multi-
stage sampling method in which a population quota was
firstly allocated to the rural and urban levels in Ilam
province, considering the last national census in 2007.
At the next step, the list of all rural and urban health
centers of Ilam province was taken from Ilam University
of Medical Sciences. There are 63 active health centers,
including 31 rural and 32 urban, in Ilam province and
according to the number of rural and urban health
centers of each county and their related population,
several health centers were selected randomly (simple
randomization) as block levels in both urban and rural
areas. Totally, 19 health centers including 9 from rural
and 10 from urban areas were selected for this study
that was about one third of all active health centers in
the province. Then for each selected health centre,
families’ health dossier numbers 1–20 were chosen as
household levels and investigators completed the ques-
tionnaire forms for all the selected family members
aging ≥ 25 years old. If any selected family was absent for
completing the questionnaire or did not agree to partici-
pate in the study, the first house after the family dossier
number of 20 was substituted. An adjustment for design
effect and correlations among clusters was applied in
this study. Participants were informed about the study
objectives and were entered into the study if they ac-
cepted their participation orally.
Data collection procedure
All the participants who agreed to participate in the
study were requested to attend in the nearest health
centre for interview and laboratory test and those who
could not attend or did not consent, were excluded. The
information related to fasting blood sugar (FBS) taken
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taking a blood sample) had already been prepared in a
sheet and was submitted to each family at the day before
the test. The importance of fasting before the test was
explained, face to face, by questioners during the distri-
bution of information sheets. If, for any reasons, the fast-
ing was broken by the participants, the candidate person
was excluded from the study.
Each participant was taken 2–3 cc vein blood sample
after which the specimens were centrifuged and sepa-
rated within 30–45 min following collection. The plasma
of each sample was separated by centrifugation at
1542 × g (~3000 rpm)/5 min (room temperature) with
an interval time of plasma separation of 2 h. The sepa-
rated samples were then transferred to Ebnsina labora-
tory by cold packs or dry ice within 30 min to maximum
3 h, depending on the distances between different coun-
ties and the laboratory centre. The FBS results equal to
7 ± 0.17 mmol/l (126 ± 3 mg/dl) were retested for cer-
tainty and a FBS ≥7 mmol/l (126 mg/dl) was considered
as abnormal. Quality control was assayed each time the
glucose method was performed by Westgard rules [17].
According to these rules controls were analyzed at the
beginning of each run, periodically throughout and at
the end of the run.
Demographic data were collected via interview and
completing a validated questionnaire including age, sex,
place of life, marital status, history of hypertension, fam-
ily diabetes, daily exercise, smoking, weekly consumption
of fruit, or animal oil. The data related to weight was
then collected using a calibrated electronic digital scale,
accurate to 100 g (Soehnle, Murrhardt, Germany) with
subjects wearing only light underwear. Heights were
measured to the nearest 0.1 cm using a Seca portable
stadiometer while wearing no shoes and waist size was
measured using a cloth tape measure by placing the tape
measure midway between the hip bone and the bottom
of lower ribs under the dresses.
Respondents were asked to report the frequency of
consumption of a given serving of fruits or animal oil on
a daily, weekly and monthly basis and data were then
converted to weekly intake frequency and for daily exer-
cise, participants were asked to report their daily or
weekly physical activities (as hours) regardless of activ-
ities associated with their jobs and then converted to
daily exercise.Study definitions
Hyperglycemia was considered as an abnormally (greater
than the upper limit of the normal range) high concen-
trations of glucose in the circulating blood. In our study,
hyperglycemia comprised IFG (pre-diabetes), unknown
and confirmed diabetes.World Health Organization (WHO) criteria for im-
paired fasting glucose differs from the American Diabetes
Association (ADA) or Diabetes UK criteria, because the
normal range of glucose is defined differently by each.
Fasting plasma glucose levels of 5.5 mmol/l (100 mg/dl)
and higher have been shown to significantly increase the
complication rates; however, WHO opted to keep its nor-
mal upper limit under 6.1 mmol/l (110 mg/dl) to avoid
the diagnosis of too many people with impaired fasting
glucose, whereas the ADA and Diabetes UK lowered the
normal upper limit to a fasting plasma glucose under
100 mg/dl [18–20].
 The normal range by WHO criteria: fasting plasma
glucose level lower than 6.1 mmol/l (110 mg/dL)
 The normal range by ADA criteria: fasting plasma
glucose level lower than 5.6 mmol/L (100 mg/dL)
 The normal range by Diabetes UK criteria: fasting
plasma glucose level from 3.9 mmol/l (70 mg/dL) to
5.5 mmol/L (100 mg/dL)
Data analysis
All demographic and laboratory results were entered
into a validated form and were then analysed using SPSS
16. Descriptive and regression analysis were used to esti-
mate the prevalence of IFG, diabetes, hyperglycaemia
and the effects /weights of each variable on these abnor-
malities. Descriptive tables were used to show the results
and the mean value of different variables were compared
using t-test or Chi squared accordingly.
Ethical considerations
This study was approved by ethic committee of Ilam
University of Medical Sciences and was also financially
supported by this university. Patients were entered into
the study freely and did not pay for their FBS tests.
Results
A total of 2158 people were evaluated in this study, among
which 72 % were female with a mean age of 45.5 ±
14 years. 40 % of the participants were from rural regions
and 60 % from urban area. The mean height (cm), weight
(kg), FBS (mmol/l (mg/dl)) and waist (cm) of participants
were as follows respectively: 164 ± 8.9, 68.4 ± 12.3, 5.7 ±
2.8 mmol/l (102.6 ± 49.9) and 82.3 ± 14.3. Most partici-
pants were married with a figure of 91.5 %. The
prevalence of IFG, diabetes and hyperglycaemia among
participants were 7.8 %, 11.8 % and 19.6 %, respectively
and participants from urban area showed a significantly
higher prevalence of hyperglycaemia than rural re-
gions (P < 0.0001) (Table 1). The prevalence rates of
IFG, diabetes and hyperglycemia, all showed a positive
relationship with age among the participants (Table 2).
The comparisons between different levels of plasma
Table 1 Frequency of different variables related to the participants of the diabetes study in Ilam Province




Age (years) 45.5 ± 14 - - -
Height (Centimeter) 163.9 ± 8.9 - - -
Weight (kg) 68.4 ± 12.3 - - -
FBS mmol/l (mg/dl) 5.7 ± 2.8
(102.6 ± 49.9)
- - -
Waist size (Centimeter) 82.3 ± 14.3 - - -
Gender Male - 602 (28) - -
Female - 1553 (72) - -
Place of life Urban - 1288 (60) - -
Rural - 870 (40) - -
Marital status Unmarried - 98 (4.5) - -
married - 1974 (91.5) - -
Widow - 60 (3) - -
History of HT - - 238 (11 %) 1912 (89 %)
Weekly serving of fruits - - 2082 (97 %) 72 (3 %)
History of family diabetes - - 192 (9 %) 1901 (88 %)
Daily exercise - - 1822 (85 %) 322 (15 %)
Smoking - - 103 (5 %) 2052 (95 %)
Weekly serving of animal oil - - 567 (26 %) 1581 (74 %)
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available in Tables 3 and 4.
Logistic regression was applied for 12 different variables
investigated in this study and 6 variables of family history
of diabetes, age, hypertension, marital status, place of life
and smoking were identified more frequently in relation
with disturbances of serum glucose levels. The method
used for logistic regression analysis was “enter” or stand-
ard regression analysis and all the categorical predictor
values were firstly defined and selected in the model. The
logistic regression was applied for diabetes, IFG and
hyperglycemia, as dependent variables, in three separated
times (each time one dependent variable) with the same
method. The results of univariate and multivariate analysis
are summarized in Tables 5 and 6. Four of the identified
risk factors were evaluated by yes/no answers and the two
variables of place of life and age were respectively evalu-
ated based on whether the participants were living in a
rural or urban area and if they were in an age group lower
or higher than 50 years old. According to this analysis, the
highest coefficient was related to positive history of dia-
betes, i.e., the possibility of having a serum glucose dis-
turbance among those with a positive history of diabetes
was more than those without. The availability rate of dif-
ferent variables to be included in the final analysis is
shown by Table 7.Discussion
The prevalence of IFG, diabetes and hyperglycaemia
among participants in the current study were 7.8, 11.8 and
19.6 %, respectively and participants from urban area
showed a higher prevalence of hyperglycaemia than those
from the rural regions. A study from Iran in 2009 reported
a prevalence of 16.3 % for diabetes in Yazd city and also
reported that 14–23 % of the Iranian population, with the
age higher than 30 years old, are suffering from diabetes
or IFG [21]. These figures are higher than what have been
indicated in the current study. More studies from Iran by
Janghorbani et al., Azizi et al., and Larijani et al., during
1997–2005 [22–25], reported prevalence rates of 4.6–10 %
for diabetes which are more closed to what has been re-
ported by the current study compared to the study in
Yazd. The distribution of diabetes in Iran has been the
subject of several surveys. Disease prevalence rates, for all
forms of diabetes, have been variously reported as 7–17 %
in several adult urban populations. However, geographical
prevalence is not uniform and the prevalence of type 2
diabetes mellitus has been reported at 3–5 % in rural com-
munities. A screening program conducted at different
locations of Iran revealed that nearly 50 % of people
with type 2 diabetes were unaware of their conditions
[24]. Another national cross-sectional survey among
70,981 Iranian citizens, aged 25–64 years, found that
Table 2 Frequency of participants according to the different plasma glucose levels and related prevalence









<70 70–110 111–125 ≥126 Total
Place of life Rural 36 707 46 81 870 5.3 (4.7–5.6) 9.3 (8.9–9.6) 14.6 (14.3–15.0) 0.000
Urban 86 907 122 173 1288 9.5 (9.1–10.0) 13.4 (12.8–13.7) 22.9 (22.0–23.6)
Total 122 1614 168 254 2158 8.2 (7.8–8.6) 11.8 (11.3–12.2) 20 (19.2–20.9)
Gender Male 27 447 55 73 602 9.1 (8.6–9.5) 12.1 (11.7–12.6) 21.2 (20.6–21.9) 0.324
Female 95 1164 113 181 1553 7.3 (6.7–7.8) 11.7 (11.1–12.3) 19 (18.5–19.7)
Total 122 1611 168 254 2155 7.8 (7.2–8.3) 11.8 (11.4–12.1) 19.6 (19.1–20.2)
Marital status Married 113 1469 155 237 1974 7.9 (7.3–8.5) 12.3 (11.7–12.9) 20.2 (19.4–21.0) 0.033
Unmarried 7 81 6 4 98 6.1 (5.5–6.7) 4.1 (3.5–4.7) 10.2 (9.8–10.7)
Widow 1 42 6 11 60 10 (9.3–10.7) 18.3 (17.8–18.7) 28.3 (27.1–29.2)
Total 121 1592 167 252 2132 7.8 (7.2–8.5) 11.8 (11.3–12.4) 19.6 (19.1–20.3)
History of HT Yes 5 157 25 51 238 10.5 (10.2–10.9) 21.4 (21.0–21.8) 31.9 (30.8–32.5) 0.001
No 116 1450 143 203 1912 7.5 (7.1–7.9) 10.6 (10.3–11.0) 18.1 (17.7–18.5)
Total 121 1607 168 254 2150 7.8 (7.4–8.2) 11.8 (11.4–12.3) 19.6 (19.1–20.1)
Weekly using of fruit Yes 114 1556 164 248 2082 7.9 (7.4–8.3) 11.9 (11.4–12.6) 19.8 (19.1–20.6) 0.000
No 8 54 4 6 72 5.6 (5.1–5.9) 8.3 (7.8–8.8) 13.9 (13.0–14.7)
Total 122 1610 168 254 2154 7.8 (7.4–8.3) 11.8 (11.1–12.7) 19.6 (18.9–20.3)
History of family diabetes Yes 14 107 15 56 192 7.8 (7.5–8.1) 29.2 (28.3–29.6) 37 (36.5–37.6) 0.000
No 108 1456 50 187 1901 2.6 (2.3–3.0) 9.8 (9.4–10.2) 12.4 (11.9–12.8)
Total 122 1563 165 243 2093 7.9 (7.5–8.3) 11.6 (11.1–12.0) 19.5 (18.9–20.1)
Daily exercise Yes 104 1382 134 202 1822 7.4 (7.0–7.9) 11.1 (10.6–11.5) 18.5 (18.1–19.2) 0.000
No 18 219 34 51 322 10.6 (10.3–11.0) 15.8 (15.1–16.7) 26.4 (25.2–27.4)
Total 122 1601 168 253 2144 7.8 (7.4–8.1) 11.8 (11.0–12.7) 19.6 (18.8–20.4)
Smoking Yes 4 73 12 14 103 11.7 (11.3–12.2) 13.6 (13.1–14.0) 25.3 (24.6–26.1) 0.000
No 118 1538 158 240 2052 7.7 (7.2–8.1) 11.7 (11.2–12.1) 19.4 (18.6–20.2)
Total 122 1611 168 254 2155 7.8 (7.5–8.3) 11.8 (11.1–12.4) 19.6 (18.7–20.5)
Weekly using of animal oil Yes 24 428 53 62 567 9.3 (8.1–10.4) 10.9 (10.2–11.7) 20.2 (19.5–21.0) 0.028
No 97 1177 115 192 1581 7.3 (6.2–8.1) 12.1 (11.5–12.8) 19.4 (18.6–20.5)
Total 121 1605 168 254 2148 7.8 (6.9–9.0) 11.8 (11.1–12.6) 19.6 (18.8–20.6)
Age group (years) 25–40 69 724 52 59 904 5.8 (4.5–6.8) 6.5 (5.9–7.0) 12.3 (11.7–12.9) 0.000
41–60 43 672 77 141 933 8.3 (7.1–9.5) 15.1 (14.4–15.7) 23.4 (22.1–24.9)
>60 10 218 39 54 321 12.2 (11.6–12.9) 16.8 (16.2–17.4) 29 (27.9–31.1)
Total 122 1614 168 254 2158 7.8 (6.7–9.6) 11.8 (11.2–12.8) 19.6 (18.1–20.9)
HT hypertension, FBS fasting blood glucose
aFBS: <3.9 mmol/l = <70 mg/dl; FBS: 3.9–6.1 mmol/l = 70–110 mg/dl; FBS: 6.12–6.9 mmol/l = 90–125 mg/dl; FBS: ≥7 mmol/l (≥126 mg/dl)
bPr: prevalence
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diabetes, among whom one-half were undiagnosed. An
additional 16.8 % (4.4 million) of Iranian adults have
impaired fasting glucose [26]. Therefore, this high rate
of lack of awareness for serum glucose status may in-
crease the chances of diabetes complications among
Iranian population.
The prevalence of type 2 diabetes appears to be high
among Iranian people over 40 years old with a figure of24 % which increases by 0.4 % each year after the age of
20 years. In a study, it was reported that the risk of type
2 diabetes was 1.7 % greater in women compared to
men [27]. It seems that the crude prevalence is not an
appropriate indicator, due to differences in age pyramids,
and an age-adjusted or age-specific prevalence should be
used for this purpose.
Though our results showed a higher diabetes preva-
lence rate in Ilam province compared to the overall rate
Table 3 Plasma glucose level of participants of the Ilam diabetes study, according to their weight groups
Variables Weight group (kg)
Under 50 50–60 61–70 71–80 81–90 91–100 ≥100 Total
Plasma glucose
level
<3.9 mmol/l (<70 mg/dl) (n) 9 27 46 46 10 4 0 122
3.9–6.1 mmol/l (70–110 mg/dl) (n) 95 331 552 552 148 41 22 1568
6.1–6.9 mmol/l (111–125 mg/dl)
(n)
0 38 63 63 11 8 2 162
≥7 mmol/l (≥126 mg/dl) 15 56 79 79 27 8 1 246
Total (n) 119 452 740 740 196 61 25 2099
IFG prevalence% (95%CI) 0 8.4 (8.1–8.8) 8.5 (8.1–8.9) 8.5 (8.1–8.9) 5.6 (5.4–5.8) 13.1 (12.7–13.5) 8 (7.5–8.4) 7.7 (7.2–8.1)
Diabetes prevalence% (95%CI) 12.6 (12.2–12.9) 12.4 (12.0–12.8) 10.7 (10.1–11.2) 10.7 (10.1–11.2) 13.8 (13.4–14.3) 13.1 (12.6–13.5) 4 (3.3–4.6) 11.7 (11.2–12.1)
















Table 4 Plasma glucose level of participants of the Ilam diabetes study, according to their waist size groups and gender
Men waist size group (cm)
Variable Under 94 94–102 >102 Total
Plasma glucose level <3.9 mmol/l (<70 mg/dl) (n) 17 3 3 23
3.9–6.1 mmol/l (70–110 mg/dl) (n) 224 62 37 323
6.1–6.9 mmol/l (111–125 mg/dl) (n) 33 2 1 36
≥7 mmol/l (≥126 mg/dl) 36 1 7 48
Total (n) 310 68 48 426
IFG Prevalence% (95%CI) 10.65 (10.3–11.0) 2.9 (2.3–3.4) 2.1 (1.8–2.5) 8.5 (8.1–8.8)
Diabetes prevalence% (95%CI) 11.6 (11.3–12.1) 1.5 (1.1–2.0) 14.6 (14.2–14.9) 11.3 (10.9–11.7)
Hyperglycaemia prevalence% (95%CI) 22.3 (21.8–22.6) 4.4 (4.1–4.8) 16.7 (16.2–17.1) 19.7 (19.3–20.2)
Women waist size group (cm)
Plasma glucose level <3.9 mmol/l (<70 mg/dl) (n) under 80 80–88 >88 Total
49 17 17 83
3.9–6.1 mmol/l (70–110 mg/dl) (n) 390 209 230 829
6.1–6.9 mmol/l (111–125 mg/dl) (n) 42 20 15 77
≥7 mmol/l (≥126 mg/dl) 57 37 28 122
Total (n) 538 283 290 1111
IFG prevalence% (95%CI) 7.8 (7.1–8.2) 7.1 (6.7–7.5) 5.2 (4.9–5.6) 6.9 (6.4–7.3)
Diabetes prevalence% (95%CI) 10.6 (10.2–10.9) 13.1 (12.9–13.5) 9.7 (9.4–10.1) 11.0 (10.7–11.2)
Hyperglycaemia prevalence% (95%CI) 18.4 (18.0–18.7) 20.1 (19.7–20.6) 14.8 (14.3–15.5) 17.9 (17.5–18.3)
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lence rates reported from some other provinces such as
Yaz (14.01 %), Kerman (13.16 %), Qazvin (13.09 %),
Bushehr (12.62 %), and Isfahan (12.19 %). On the other
hand, this prevalence rate is much higher than that in
Kurdistan (3.35 %), Lorestan (3.62 %), Gilan (4.45 %),
Zanjan (4.62 %) and some other provinces [27]. These
discrepancies may be associated with verity of diabetes –
related risk factors in different geographical areas in Iran
or differences in the methodology applied by different
studies performed.
Studies from other parts of the world have reported ei-
ther higher or lower prevalence of hyperglycaemia and
IFG than the figure reported by the current study, which
could be due to the effects of geographical conditions,
nutritional habits, racial and genetically differences, cus-
toms, social behaviors and different life styles on dia-
betes and IFG. A study from the USA [4] in 2002, has
reported a prevalence rate of 38 % for hyperglycaemia
among hospitalized patients but another study investi-
gated unrecognised diabetes among patients with coron-
ary diseases and found that 46.6 % of patients had
hyperglycaemia with no prior history of diabetes [5].
Amongst the top ten countries with the highest preva-
lence rates of diabetes, three are from the Middle East and
North Africa Regions including Saudi Arabia, Kuwait, and
Qatar with prevalence rates of 24, 23.1 and 22.9 %,respectively. Indeed, many of the countries in the Middle
East and North Africa Regions have prevalence rates well
above the global prevalence of 8.3 %, among which Egypt
(15.6 %), Turkey (14.6 %), UAE (10 %) and Tunisia (9.2 %)
have the highest prevalence rates, after the 3 above men-
tioned countries [28]. Iran with a total prevalence rate of
8.4 % has approximately a similar rate to the global figure.
As diabetes is a disease with multifactorial causes, associ-
ated with social, behavioral, occupational, life style and
other factors, the discrepancies in its prevalence rates
among different geographical regions, nations, societies
and even different races in a city could be justifiable.
Community based studies, similar to the current study,
have reported different prevalence of hyperglycaemia.
For example, Cowie and others from the USA have re-
ported a prevalence rate of 26 % for IFG [9]; however,
Meisinger and colleagues from Germany have reported
an overall prevalence of 16 % for either diabetes or ab-
normalities of glucose metabolism [10] and Sakikawas’
study from Japan reported a figure of 12.9 % [11].
The above mentioned studies were some samples of
the developed countries; however, studies from develop-
ing countries have reported similar discrepancies for
hyperglycaemia prevalence. A study from south of India
by Mohan in 2003, reported a prevalence rate of 5.9 %
for IFG and 7.2 % for diabetes [14] but another study by
Shera from Pakistan in 2010, reported a prevalence of
Table 5 Weighting given to different risk factors associated with diabetes, IFG and hyperglycaemia after univariate analysis
Type of disorder Variable Weighting Exp (B), (95 % CI) P value
Diabetes Positive Family of diabetes Yes 56.647 3.265, 2.87–3.66 0.000
Nob
Age >50 years 35.126 2.224,1.71–2.89 0.000
≤50 yearsb
History of hypertension Yes 22.676 1.436, 1.14–1.83 0.000
Nob
Place of life Urban 8.406 1.511, 1.14–1.99 0.004
Ruralb
At least 30 min daily exercise Yesb 5.870 1.509, 1.08–2.11 0.015
No
Married Yes 5.615 2.731, 1.19–6.27 0.018
Nob
Female Waist size >88 cm 3.169 0.779, 0.62–1.03 0.075
≤88bcm
Male Waist size >102 cm 2.321 1.332, 0.76–1.84 0.091
≤102bcm
Weekly using of fruit Yesb 0.846 0.672, 0.29–1.57 0.358
No
Weekly using of animal oil Yes 0.585 1.126, 0.83–1.53 0.444
Nob
Smoking Yes 0.338 0.842, 0.47–1.5 0.561
Nob
Sex Male 0.093 0.956, 0.72–1.28 0.761
Femaleb
BMI >25 0.063 1.034, 0.79–1.34 0.801
≤25b
IFG History of hypertension Yes 19.448 1.538,0.58–1.13 0.000
Nob
Place of life Urban 18.685 1.672, 1.32–2.11 0.000
Ruralb
Male Waist size >102 cm 12.331 1.812, 1.23–2.14 0.000
≤102bcm
Female Waist size >88 cm 9.881 1.691, 1.43–1.97 0.002
≤88bcm
Married Yes 8.728 2.687, 1.39–5.27 0.003
Nob
Age >50 years 6.234 1.332, 1.06–1.67 0.013
≤50 yearsb
Smoking Yes 3.303 0.654, 0.41–1.03 0.069
Nob
Positive Family of diabetes Yes 2.921 1.099, 0.74–1.63 0.089
Nob
Weekly using of animal oil Yes 2.884 0.812, 0.64–1.03 0.638
Nob
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Table 5 Weighting given to different risk factors associated with diabetes, IFG and hyperglycaemia after univariate analysis
(Continued)
At least 30 min daily exercise Yesb 2.679 1.275, 0.95–1.71 0.102
No
Sex Male 2.135 0.838, 0.66–1.06 0.144
Femaleb
Weekly using of fruit Yesb 0.504 0.790, 0.41–1.52 0.478
No
BMI >25 0.286 1.061, 0.85–1.32 0.593
≤25b
Hyperglycaemia Positive Family of diabetes Yes 25.743 2.459, 1.93–2.86 0.000
Nob
Age >50 years 39.798 1.846, 1.53–2.23 0.000
≤50 yearsb
Place of life Urban 32.358 1.758, 1.45–2.14 0.000
Ruralb
History of hypertension Yes 19.448 1.538, 1.31–1.78 0.000
Nob
Married Yesb 16.999 2.071, 1.8–5.24 0.000
No
Male Waist size >102 cm 16.684 1.731, 1.12–2.34 0.000
≤102bcm
Female Waist size >88 cm 15.255 1.681, 1.56–1.83 0.001
≤88bcm
At least 30 min daily exercise Yesb 9.508 1.475, 1.15–1.89 0.002
No
Smoking Yes 3.773 0.668, 0.44–1.04 0.052
Nob
Sex Male 2.098 0.861, 0.71–1.65 0.148
Femaleb
Weekly using of fruit Yesb 1.550 0.704, 0.41–1.22 0.213
No
BMI >25 0.394 1.061, 0.88–1.26 0.530
≤25b
Weekly using of animal oil Yes 0.805 0.910, 0.74–1.12 0.370
Nob
Exp (B) a: Indicates the odds of having the disease (e.g., diabetes) among those with the risk factor (e.g., Family diabetes) compared to those without that risk
factor. breference group
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for females [16].
The current study showed that the prevalence of hyper-
glycaemia and IFG among urban population was signifi-
cantly higher compared to rural population. Though not
significant, our study showed a higher prevalence of dia-
betes and IFG among males compared to females; how-
ever, other studies from Pakistan [16] and Colombia [12]reported a higher prevalence among females. A study by
Sarah Wild and others in 2004 also reported a higher
prevalence of diabetes among males compared to
females [29].
According to the results of the current study, differ-
ent cities of Ilam province have also shown different
prevalence rates of diabetes and IFG from a minimum
of 5.3 % in Aivan county to a maximum of 14.8 % in
Table 6 Weighting given to different risk factors associated with diabetes, IFG and hyperglycaemia after multivariate analysis
Type of disorder Variable Weighting Exp (B)a, (95 % CI) P value
Diabetes Positive Family of diabetes Yes 48.862 3.616, 2.52–5.19 0.000
Nob
Age >50 years 17.567 1.526, 1.22–1.84 0.000
≤50 yearsb
History of hypertension Yes 7.244 1.697, 1.15–2.53 0.007
Nob
Place of life Urban 8.387 1.629, 1.37–1.89 0.004
Ruralb
Married Yes 3.791 1.558, 1.24–2.31 0.041
Nob
Smoking Yes 2.234 1.042, 0.099–1.44 0.048
Nob
Female Waist size >88 cm 2.134 1.283, 0.92–1.83 0.144
≤88bcm
Male Waist size >102 cm 2.107 1.461, 0.87–2.44 0.147
≤102bcm
Weekly using of fruit Yesb 0.555 1.395, 0.58–3.35 0.456
No
Weekly using of animal oil Yes 0.542 0.886, 0.64–1.22 0.461
Nob
BMI >25 0.324 0.9190.69–1.23 0.569
≤25b
At least 30 min daily exercise Yesb 0.318 0.899, 0.62–1.30 0.573
No
Sex Male 0.014 0.981, 0.71–1.35 0.905
Femaleb
IFG Place of life Urban 14.057 1.616, 1.48–1.79 0.000
Ruralb
Married Yes 9.065 1.300, 1.137–1.66 0.003
Nob
Male Waist size >102 cm 6.12 1.711, 1.12–2.62 0.013
≤102bcm
Positive Family of diabetes Yes 4.228 1.907, 0.61–1.35 0.03
Nob
Weekly using of animal oil Yes 3.000 1.246, 0.97–1.68 0.083
Nob
Smoking Yes 2.795 1.211, 0.74–1.97 0.095
Nob
Female Waist size >88 cm 2.542 1.256, 0.96–1.65 0.098
≤88bcm
Age >50 years 2.272 0.824, 0.64–1.06 0.132
≤50 yearsb
BMI >25 2.157 0.838, 0.66–1.061 0.142
≤25b
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Table 6 Weighting given to different risk factors associated with diabetes, IFG and hyperglycaemia after multivariate analysis
(Continued)
Sex Male 2.015 0.831, 0.64–1.07 0.156
Femaleb
Weekly using of fruit Yesb 0.184 1.157, 0.65–2.25 0.668
No
History of hypertension Yes 0.718 1.171, 0.81–1.75 0.397
Nob
At least 30 min daily exercise Yesb 0.273 0.919, 0.67–1.26 0.601
No
Hyperglycaemia Positive Family of diabetes Yes 27.876 2.154, 1.63–2.95 0.000
Nob
Age >50 years 22.211 1.626, 1.504–1.78 0.000
≤50 yearsb
History of hypertension Yes 18.012 1.563, 1.15–2.13 0.005
Nob
Married Yes 12.240 1.343, 1.19–1.63 0.000
Nob
Place of life Urban 11.438 1.161, 1.45–1.77 0.000
Ruralb
Male Waist size >102 cm 9.721 1.76, 1.23–2.51 0.002
≤102bcm
Female Waist size >88 cm 6.057 1.341, 1.06–1.75 0.014
≤88bcm
BMI >25 3.084 0.832, 0.68–1.02 0.079
≤25b
Smoking Yes 1.372 1.149, 0.74–1.79 0.542
Nob
Weekly using of animal oil Yes 1.003 1.119, 0.89–1.44 0.317
Nob
Sex Male 1.553 0.867, 0.69–1.15 0.213
Femaleb
Weekly using of fruit Yesb 0.770 1.293, 0.73–2.33 0.380
No
At least 30 min daily exercise Yesb 0.715 0.888, 0.68–1.17 0.398
No
Exp (B) a: Indicates the odds of having the disease (e.g., diabetes) among those with the risk factor (e.g., Family diabetes) compared to those without that risk
factor. b: reference group
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of 1.9 % in Aivan county to a maximum of 11.8 % in
Chardavel county for IFG. These discrepancies may
be related to the effects of geographical, customs, so-
cial behaviors and nutritional conditions on diabetes
and IFG.
The prevalence of IFG, diabetes and hyperglycaemia
among singles, married and widows were 6.1, 4.1, 10.2;7.9, 12.3, 20.2 % and 10, 18.3, 28.3 %, respectively. This
can indicate the effects of mean age on IFG and diabetes
among married and widows compared to singles and the
effect of age on IFG and diabetes is a recognized factor.
There was a significant difference between the
prevalence of IFG, diabetes and hyperglycemia among
those with hypertension compared to those without
(10.5 %, 21.4 %, 31.9 % vs 7.5 %, 10.6 %, 18.1 %
Table 7 The availability rate of different variables. ‘Classes’ indicates the percentage of participants falling within each variable
group. Some classes do not sum to 100 % within each indicator because of missing data, so ‘Available results’ reports the




Total Classes% Available results %
FBS 2158 100 100 0
Weight 2101 97.4 97.4 2.6
Height 2104 97.5 97.5 2.5
Waist size male 436 28.4 71.2 28.8
female 1100 71.6
Gender Male 652 28 100 0
female 1506 72
BMI <25 998 48 96.3 3.7
25–30 870 41.9
>30 210 10.1
Age group 25–40 898 41.8 99.5 0.5
41–60 929 43.3
>60 321 14.9
At least 30 min daily exercise Yes 1822 85 97.4 2.6
No 322 15
History of hypertension Yes 238 11.1 97.6 2.4
No 1912 88.9
Weekly using of animal oil Yes 567 26.4 97.5 2.5
No 1581 73.6
Family diabetes Yes 192 9.2 97.0 3
No 1901 90.8
Daily smoking Yes 103 4.8 97.9 2.1
No 2052 95.2
Weekly using of fruit Yes 2082 96.7 97.8 2.2
No 72 3.3
Place of life Rural 870 40 100 0
Urban 1288 60
Marital status Single 98 4.6 98.8 1.2
Married 1974 92.6
Widow/widower 60 2.8
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tween the history of hypertension and aggravation of
IFG or diabetes should be approved by future studies.
The current study showed a significantly higher preva-
lence of hyperglycaemia among those with a history of
family diabetes (37 %) compared to those without
(12.4 %). This difference has already been shown as a
recognized factor by other references [29].
The prevalence of IFG, diabetes and hyperglycaemia
was significantly higher among smokers, compared to
non- smokers (11.7 %, 13.6 %, 25.3 % vs. 7.7 %, 11.7 %,19.4 %, respectively). More studies need to approve the
effects of this factor on diabetes and IFG.
There was a significantly positive relationship between
age and diabetes or IFG. For example, the 9.8 and 24 %
prevalence of diabetes among participants with the age
group of 21–30 years and those with the age group of
71–80 years were reported respectively [29].
Another factor related to diabetes in the current study
was height. The prevalence rate of diabetes was 5.6 %
among the participants with a height of 150 cm or less
and 18.1 % among those with a height above 170 cm.
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height, this process may be related to the effects of age
on diabetes which has already been approved. Regardless
of age, the pure effects of height on diabetes should be
investigated by future studies.
There was a positive relationship between the preva-
lence of diabetes and waist size among men; for ex-
ample, participants with a mean waist size of 70 cm had
a diabetes prevalence of11.6 % compared to those with a
mean waist above 102 cm who had a prevalence of
14.6 %. This could be due to accompany of fatness with
higher waist size and the effects of fatness on diabetes
has already been recognized [30].
This study was the first comprehensive population
based survey for type 2 diabetes in Ilam province which
could be used as a pilot study for any future interven-
tional or preventive issues or academic researches in this
province. A self-assessment predictive model for dia-
betes could be constructed upon the results of this study
and we are now working on this model which could be
applied by other provinces in the western part of Iran.
This study also has some limitations such as lower pro-
portion of recruited males and excess of participated
women in the study, not a 100 % availability rate for all
the variables, and not performing GTT for diabetes con-
firmation when FBS was higher than 126 mg/dl. Data
collection and blood sampling were performed in the
morning and in that particular time men were usually
outside the home or not interested to participate in the
study. However, there was a relatively large number of
participants in this study and notwithstanding the excess
number of women, there was still enough number of
participated men for investigation and comparison of
different variables.
Conclusions
The regression analysis revealed that the most effective
factors associated with IFG and diabetes were family his-
tory of diabetes, age, hypertension, marital status, place
of life and smoking, respectively. The prevalence of IFG,
diabetes and hyperglycemia among population living in
Ilam province, west of Iran, were 7.8, 11.8 and 19.6 %,
respectively which were increased with age.
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